NIH-funded research Sbir 1 grant

Engineered nitric oxide releasing IV catheters with solid slippery surfaces to prevent infection and clotting

Official title: Engineering Nitric Oxide Releasing Intravascular Catheters with Solid Slippery Surfaces to Combat Infection and Thrombosis

Funded at Nytricx INC. · NIH-11313954 · Data updated 2026-11-12

A patient-facing overview of a new coating for short-term vascular access catheters that aims to lower risk of infection and blood clots.

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionNytricx INC.
NIH-funded
Lab location1 site (Athens, United States)
Project startAugust 1, 2026
Project endJuly 31, 2027
Funding year2026
Award (this year)$314,337
NIH project number1R43HL184590-01
Project IDNIH-11313954 on NIH RePORTER

Who could benefit from this research

Could help

People requiring short-term vascular access devices (e.g., central venous or midline catheters) who may benefit from reduced infection and thrombosis risk.

Less likely to help

Patients not needing short-term vascular access or who already have well-protected catheters may see less direct benefit.

What this research studies

This project develops advanced catheter surfaces that steadily release nitric oxide and incorporate solid slippery coatings to resist bacteria and protein buildup. By combining NO release with slippery, low-friction surfaces, the approach aims to reduce infections and thrombosis in people who need short-term central lines. If successful, these coatings could extend catheter life and lower antibiotic use without requiring new patient procedures. The research involves translating lab findings into materials that could be used in human care with iterative testing and optimization.

Why it matters

Potential benefit: If successful, patients could experience fewer catheter-related infections and clots, potentially shorter hospital stays and less antibiotic exposure.

How similar studies have gone: Prior work shows NO-releasing materials can reduce infection and clotting; this project explores a robust solid slippery coating to enhance protection.

Where this research is happening

  • Nytricx INC.
    Athens, United States
    Active

Researchers

  • Principal investigator: Shebuski, Ronald J. — Nytricx INC.
  • Study coordinator: Shebuski, Ronald J.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.